A lawsuit that drugmaker Novo Nordisk filed on Monday against telehealth firm Hims & Hers shows how fierce the maneuvering over the booming obesity-drug market has become. In the lawsuit filed in a ...

Hims & Hers Health launched a cheaper, compounded version of the new Wegovy pill in a move that reignites its competition with Novo Nordisk in the U.S. obesity-drug market. Shares of of Hims & Hers ...

Novo Nordisk Chief Executive Officer Mike Doustdar talks about the company's outlook as it faces headwinds on its main obesity and diabetes drugs and its shares plunged. Doustdar tells Bloomberg ...

Novak Djokovic might have lost the final of the Australian Open on Sunday (February 1), but he won hearts with his wonderful gesture towards Rafael Nadal during the summit clash at the Rod Laver Arena ...

It was exactly what the tennis world was waiting for. Rafael Nadal made sure not to take sides heading into the Australian Open final between his compatriot Carlos Alcaraz and long-time rival Novak ...

Novo Nordisk obtained approval for its GLP-1 weight loss pill late last year. The company has already launched the drug, and there were more than 18,000 prescriptions in the U.S. in just its first ...

In case you've faced some hurdles solving the clue, Established lore in a video game, e.g., we've got the answer for you. Crossword puzzles offer a fantastic opportunity to engage your mind, enjoy ...

Pair share insights while building anticipation for the season’s first Grand Slam Dubai: Filipino tennis prodigy Alexandra Eala continues to make steady strides on the global stage, further ...

Madison Muller, Bloomberg News health reporter, says that the failure of a long-shot trial to see if the pill form of Novo Nordisk's weight loss drug Ozempic impacted Alzheimer's was the latest in a ...

Rafael Nadal had a reunion with some of his most notorious friends over the weekend. The Spanish tennis star traveled all the way to Biscayne Bay, Miami, to attend this year's E1 Miami GP, an electric ...

Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG Novo Nordisk CEO Mike Doustdar tells CNBC he has huge confidence in the company's pipeline as it narrows its guidance and sweetens its offer ...

Fast food giant McDonalds topped forecasts after a very encouraging earnings report which included a rise of 3.6% in same store sales. Meanwhile, pharma giant Novo Nordisk had to lower its full-year ...